2018
DOI: 10.1016/j.msard.2018.10.082
|View full text |Cite
|
Sign up to set email alerts
|

Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles